These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3885512)

  • 1. Bone marrow transplantation following treatment with high-dose melphalan.
    Dale BM; Sage RE; Norman JE; Barber S; Kotasek D
    Transplant Proc; 1985 Apr; 17(2):1711-3. PubMed ID: 3885512
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of Ewing's sarcoma with high-dose melphalan and autologous bone marrow transplantation.
    Cornbleet MA; Corringham RE; Prentice HG; Boesen EM; McElwain TJ
    Cancer Treat Rep; 1981; 65(3-4):241-4. PubMed ID: 7016319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose melphalan with autologous bone marrow rescue for the treatment of advanced adult solid tumors.
    Maraninchi D; Abecasis M; Gastaut JA; Herve P; Sebahoun G; Flesch M; Blanc AP; Carcassonne Y
    Cancer Treat Rep; 1984 Mar; 68(3):471-4. PubMed ID: 6367977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
    Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR
    Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose melphalan allows durable engraftment of allogeneic bone marrow.
    van Besien K; Demuynck H; Lemaistre CF; Bogaerts MA; Champlin R
    Bone Marrow Transplant; 1995 Feb; 15(2):321-3. PubMed ID: 7773226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional hyperactivity of monocytes after bone marrow transplantation: possible relevance for the development of post-transplant complications or relapse.
    Castenskiold EC; Kelsey SM; Collins PW; Coldwell RD; Allen PD; Side LE; Makin HL; Goldstone AH; Newland AC
    Bone Marrow Transplant; 1995 Jun; 15(6):879-84. PubMed ID: 7581085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melphalan-total body irradiation and autologous bone marrow transplantation for adult acute leukemia beyond first remission.
    Mehta J; Powles R; Singhal S; Horton C; Tait D; Treleaven J
    Bone Marrow Transplant; 1996 Jul; 18(1):119-23. PubMed ID: 8832004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose melphalan followed by a second bone marrow transplantation in early relapse of acute myeloid leukemia after bone marrow transplantation in children.
    Tempescul A; Ianotto JC; Eveillard JR; Guillerm G; Berthou C; Marion V; De Braekeleer M
    Ann Hematol; 2008 Jun; 87(6):503-4. PubMed ID: 18172644
    [No Abstract]   [Full Text] [Related]  

  • 9. Melphalan alone prior to allogeneic bone marrow transplantation from HLA-identical sibling donors for hematologic malignancies: alloengraftment with potential preservation of fertility in women.
    Singhal S; Powles R; Treleaven J; Horton C; Swansbury GJ; Mehta J
    Bone Marrow Transplant; 1996 Dec; 18(6):1049-55. PubMed ID: 8971372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of metastatic malignant melanoma with intensive melphalan and autologous bone marrow transplantation.
    Lazarus HM; Herzig RH; Wolff SN; Phillips GL; Spitzer TR; Fay JW; Herzig GP
    Cancer Treat Rep; 1985 May; 69(5):473-7. PubMed ID: 3891085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High dose melphalan with autologous marrow rescue in cancer treatment.
    Dewar JM; Forgeson GV; Dady PJ
    N Z Med J; 1984 Nov; 97(768):816-8. PubMed ID: 6390271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful paternity of twins following bone marrow transplantation with busulfan, melphalan and cyclophosphamide conditioning.
    Shepherd JD; Hoar DI; Keown PA; Phillips GL
    Bone Marrow Transplant; 1996 Mar; 17(3):461-2. PubMed ID: 8704708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose melphalan with autologous hematopoietic stem cell transplantation for acute myeloid leukemia: results of a retrospective analysis of the Italian Pediatric Group for Bone Marrow Transplantation.
    Cesaro S; Meloni G; Messina C; Pillon M; Proglia A; Lanino E; Caniggia M; Bagnulo S; Pession A; Locatelli F;
    Bone Marrow Transplant; 2001 Jul; 28(2):131-6. PubMed ID: 11509930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is veno-occlusive disease incidence influenced by the total-body irradiation technique?
    Belkacémi Y; Ozsahin M; Rio B; Laporte JP; Leblond V; Pène F; Laugier A
    Strahlenther Onkol; 1995 Dec; 171(12):694-7. PubMed ID: 8545791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of bone marrow transplantation on myocardial function in children.
    Pihkala J; Saarinen UM; Lundström U; Salmo M; Virkola K; Virtanen K; Siimes MA; Pesonen E
    Bone Marrow Transplant; 1994 Feb; 13(2):149-55. PubMed ID: 8205083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary results of high-dose busulfan and cyclophosphamide with syngeneic or autologous bone marrow rescue.
    Lu C; Braine HG; Kaizer H; Saral R; Tutschka PJ; Santos GW
    Cancer Treat Rep; 1984 May; 68(5):711-7. PubMed ID: 6373004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preparatory regimen of total body irradiation, busulphan and melphalan for allogeneic bone marrow transplantation in childhood high-risk leukemia and lymphoma.
    Yoshihara T; Naya M; Tsunamoto K; Hojo M; Hibi S; Morimoto A; Todo S; Imashuku S
    Anticancer Res; 2003; 23(2C):1739-42. PubMed ID: 12820450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancer.
    Gisselbrecht C; Extra JM; Lotz JP; Devaux Y; Janvier M; Peny AM; Guillevin L; Bremond D; Delain M; Herbrecht R; Lepage E; Maraninchi D
    Bone Marrow Transplant; 1996 Nov; 18(5):857-63. PubMed ID: 8932837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated high-dose-melphalan with autologous bone marrow transplantation in acute non lymphocytic leukemia.
    Mascret B; Maraninchi D; Gastaut JA; Camerlo J; Novakovitch G; Perrimond H; Sebahoun G; Lepeu G; Rossi F; Carcassonne Y
    Rev Fr Transfus Immunohematol; 1985 Nov; 28(5):477-88. PubMed ID: 3912925
    [No Abstract]   [Full Text] [Related]  

  • 20. Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia conditioned with busulfan, cyclophosphamide and melphalan.
    Carpenter PA; Marshall GM; Giri N; Vowels MR; Russell SJ
    Bone Marrow Transplant; 1996 Sep; 18(3):489-94. PubMed ID: 8879607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.